Sort
172,184 grants matching “inflammation”
Genetic Basis for Impaired Angiogenic Signaling in BPD
$730,135Steven Herbert Abman · University Of Colorado Denver · R01 · FY2008 · HL
Development of Anticancer Agents
$730,131William Douglas Figg · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA
National Cohort Studies of Alzheimer's Disease, Related Dementias and Air Pollution
$730,128Antonella Zanobetti · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2024 · AG
1/2 + PROmote weight loss in obese PAD patients to preVEnt mobility loss: the PROVE Trial
$730,117Mary McGrae McDermott · Northwestern University At Chicago · UH3 · FY2023 · HL
Differentiative Signals for Macrophage Activation
$730,076Stefanie N. Vogel · University Of Maryland Baltimore · R01 · FY2014 · AI
Differentiative Signals for Macrophage Activation
$730,076Stefanie N. Vogel · University Of Maryland Baltimore · R01 · FY2012 · AI
SuperGAGs for Intravesicular Treatment of Interstitial Cystitis
$730,062Robert Evan Hurst · Glycologix, Llc · R44 · FY2020 · DK
Adenosine-3 agonists for the suppression of arthritis
$730,027Inotek Pharmaceuticals Corporation · R44 · FY2002 · AR
Functional impact of IL33 polymorphisms on asthma & other Th2-mediated diseases
$730,023Kathleen C Barnes · Johns Hopkins University · R01 · FY2015 · HL
Prevalence, Pathogenesis, and Persistence of Lassa Fever in West Africa
$729,986David A Wohl · Univ Of North Carolina Chapel Hill · R01 · FY2019 · AI
How Endothelial Tetraspanins Inhibit Inflammation
$729,981Xin A Zhang · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2025 · HL
EPICARDIAL ADIPOSE TISSUE, OBESITY AND INFLAMMATION IN ATHEROSCLEROSIS
$729,975Devendra K. Agrawal · Creighton University · R01 · FY2015 · HL
Modulation of lung immunity by epithelial cells from older individuals
$729,960Anna Karolina Palucka · Jackson Laboratory · U19 · FY2024 · AI
Sex specific immune response to SARS-CoV-2 leads to chronic neurologic symptoms
$729,940Louise Deborah McCullough · University Of Texas Hlth Sci Ctr Houston · R01 · FY2022 · MH
Influence of maternal virome and HIV status on infant gut virome, growth and immunity
$729,928Heather Beryl Jaspan · Seattle Children'S Hospital · R01 · FY2024 · HD
Assessing Syndemics of Cardiovascular Disease in People with and without HIV
$729,917Michael J Silverberg · Kaiser Foundation Research Institute · R01 · FY2023 · HL
Complement in Pathogenesis and Experimental Therapy of ANCA Disease
$729,914Wenchao Song · University Of Pennsylvania · R01 · FY2022 · AI
Complement in Pathogenesis and Experimental Therapy of ANCA Disease
$729,914Wenchao Song · University Of Pennsylvania · R01 · FY2023 · AI
Complement in Pathogenesis and Experimental Therapy of ANCA Disease
$729,914Wenchao Song · University Of Pennsylvania · R01 · FY2021 · AI
Complement in Pathogenesis and Experimental Therapy of ANCA Disease
$729,914Wenchao Song · University Of Pennsylvania · R01 · FY2024 · AI
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)
$729,903Priscilla Y. Hsue · University Of California, San Francisco · R61 · FY2018 · HL
Central mechanisms and novel biomarkers of the salt-sensitivity of blood pressure
$729,900Richard David Wainford · Boston University Medical Campus · R01 · FY2018 · HL
Sleep and Cardiometabolic Health Disparities at the US/Mexico Border: The Nogales Cardiometabolic Health and Sleep (NoCHeS) Study
$729,884Michael A Grandner · University Of Arizona · R01 · FY2022 · MD
Novel Therapeutic Targets for Venous Thromboembolism
$729,855Thomas William Wakefield · University Of Michigan At Ann Arbor · R01 · FY2008 · HL
Roles for interstitial and airspace macrophages in resolution of pulmonary inflammation
$729,844Peter M Henson · National Jewish Health · R01 · FY2023 · HL